Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024. 

"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."

Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month. 

The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses. 

Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent. 

Share:
More In Business
Stretching Your Dollar: How to Decide Whether to Hire a Financial Planner
Haley Sacks, founder and CEO of Finance Is Cool, joined Cheddar News to provide tips on when hiring a financial planner is needed. "They will help you figure out exactly how to maximize your personal situation," she said. "They're going to think about your long-term plans, consider your goals and incorporate all of that into the structure that they create for you."
Restaurant Inflation Pushes Patrons to Curb Culinary Spending
Restaurant inflation was up 8.8 percent from a year ago in March, according to the latest consumer price index, and customers say they're more carefully considering their culinary spending. Cheddar News correspondent Ashley Mastronardi visited Isabelle's Osteria in midtown Manhattan to ask patrons how the higher prices are impacting their wallets.
Load More